Slow enrollment is a bad sign, no matter the reason.
If B-Cell was a flyer they wouldn’t have branched out in a big way in other directions.
This looks more and more like a company taking a new direction in preclinical and phase1/2.
It doesn’t feel great. Hard to put a valuation on it.
Hype has kept this stock up but if hype leaves the building it could be bad.
This is getting serious, page-42
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.002(3.19%) |
Mkt cap ! $338.4M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.8¢ | 4.5¢ | $572.6K | 12.36M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 47 | 4910817 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 787014 | 19 |
View Market Depth
| Last trade - 15.13pm 06/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |